The most versatile modality
Most drugs are designed to block one specific function of a disease-causing protein. But over 80% of human proteins are not accessible via this approach and are generally considered “undruggable”. Although many important drivers of disease have been known for decades, they are simply out of reach. Glue degraders circumvent this limitation as they do not rely on the requirements of traditional pharmacology. The right glue degrader can attack any given target protein in the cell and lead to its removal.
We are pioneers
As exciting as glue degraders are, they are very difficult to find. Before Proxygen was founded, there was no systematic way of identifying glue degraders. We have built and are constantly developing a highly versatile glue degrader identification platform, deploying the right tools and technologies for a given target, enabling us to quickly find glue degraders against proteins of high medical relevance.
Features
“These are trailblazing times for the pharmacology of glues, with the Proxygen team leading at the new frontier of scientific discovery. It feels like a thrilling horseback gallop, the wind in your hair as you explore new territories and vistas at exhilarating speed.”
Giulio Superti-Furga